Fabio Piscaglia
Fabio Piscaglia
Associate Professor of Internal Medicine
Email verificata su unibo.it
Titolo
Citata da
Citata da
Anno
The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications
F Piscaglia, C Nolsøe, CF Dietrich, DO Cosgrove, OH Gilja, MB Nielsen, ...
Ultraschall in der Medizin-European Journal of Ultrasound 33 (01), 33-59, 2012
11172012
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012
M Claudon, CF Dietrich, BI Choi, DO Cosgrove, M Kudo, CP Nolsøe, ...
Ultraschall in der Medizin-European Journal of Ultrasound 34 (01), 11-29, 2013
10432013
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008
M Claudon, D Cosgrove, T Albrecht, L Bolondi, M Bosio, F Calliada, ...
Ultraschall in der Medizin-European Journal of Ultrasound 29 (01), 28-44, 2008
10142008
EASL clinical practice guidelines: management of hepatocellular carcinoma
European Association For The Study Of The Liver
Journal of hepatology 69 (1), 182-236, 2018
9242018
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology
J Bamber, D Cosgrove, CF Dietrich, J Fromageau, J Bojunga, F Calliada, ...
Ultraschall in der Medizin-European Journal of Ultrasound 34 (02), 169-184, 2013
9042013
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications
D Cosgrove, F Piscaglia, J Bamber, J Bojunga, JM Correas, OH Gilja, ...
Ultraschall in der Medizin-European Journal of Ultrasound 34 (03), 238-253, 2013
8672013
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
L Bolondi, S Sofia, S Siringo, S Gaiani, A Casali, G Zironi, F Piscaglia, ...
Gut 48 (2), 251-259, 2001
7642001
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
M Kudo, RS Finn, S Qin, KH Han, K Ikeda, F Piscaglia, A Baron, JW Park, ...
The Lancet 391 (10126), 1163-1173, 2018
7042018
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization
JL Raoul, B Sangro, A Forner, V Mazzaferro, F Piscaglia, L Bolondi, ...
Cancer treatment reviews 37 (3), 212-220, 2011
4802011
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma
L Bolondi, S Gaiani, N Celli, R Golfieri, WF Grigioni, S Leoni, AM Venturi, ...
Hepatology 42 (1), 27-34, 2005
4752005
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations
F Piscaglia, L Bolondi
Ultrasound in medicine & biology 32 (9), 1369-1375, 2006
4332006
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions
L Bolondi, A Burroughs, JF Dufour, PR Galle, V Mazzaferro, F Piscaglia, ...
Seminars in liver disease 32 (04), 348-359, 2012
3962012
Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential
T Knittel, D Kobold, B Saile, A Grundmann, K Neubauer, F Piscaglia, ...
Gastroenterology 117 (5), 1205-1221, 1999
3871999
EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)
CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ...
Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017
3212017
Liver transplantation for hepatocellular carcinoma: results of down‐staging in patients initially outside the Milan selection criteria
M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ...
American Journal of Transplantation 8 (12), 2547-2557, 2008
3182008
Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy
M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ...
Hepatology 54 (6), 2055-2063, 2011
3132011
What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy
S Gaiani, L Gramantieri, N Venturoli, F Piscaglia, S Siringo, A D'Errico, ...
Journal of hepatology 27 (6), 979-985, 1997
3101997
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
G Donati, B Stagni, F Piscaglia, N Venturoli, AM Morselli-Labate, L Rasciti, ...
Gut 53 (7), 1020-1023, 2004
2942004
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion
CF Dietrich, MA Averkiou, JM Correas, N Lassau, E Leen, F Piscaglia
Ultraschall in der Medizin-European Journal of Ultrasound 33 (04), 344-351, 2012
2612012
Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective …
F Piscaglia, L Bolondi
Ultrasound Med Biol 32 (9), 1369-1375, 2006
2502006
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20